A division of the US Food and Drug Administration responsible for the regulation of drugs available to patients. The Kefauver-Harris Amendment of 1962 requires that efficacy of new drugs must be proved before they can be prescribed by physicians. In 1976 the law was extended to require that safety and efficacy of medical devices be demonstrated before they can be used in the treatment of disease or injury.